Related Experiment Video
Updated: May 2, 2026

10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
5.0K
Diffusion of two botulinum toxins type A on the forehead: double-blinded, randomized, controlled study.
Hai-Yan Jiang1, Shujun Chen, Jun Zhou
1Department of Cosmetic Dermatology, WorldPath Clinic International, Shanghai, China.
Summary
Chinese type A botulinum toxin (CBTX-A) demonstrated greater diffusion than onabotulinumtoxinA in cosmetic applications. Intradermal injections also showed less diffusion compared to subcutaneous injections.
Area of Science:
- Cosmetic dermatology
- Neuromodulation
- Pharmacodynamics
Background:
- Variations in botulinum toxin type A (BoNTA) diffusion can influence cosmetic treatment outcomes.
- Understanding diffusion characteristics is crucial for optimizing clinical application.
Purpose of the Study:
- To compare the diffusion characteristics of onabotulinumtoxinA and Chinese type A botulinum toxin (CBTX-A).
- To evaluate the impact of injection technique (intradermal vs. subcutaneous) on BoNTA diffusion.
Main Methods:
- A double-blind, randomized, self-controlled study involving 20 healthy volunteers.
- Injections of 0.05 mL (2 U) of BoNTA were administered at medial forehead (subcutaneous) and temporal forehead (intradermal) sites.
- Diffusion was assessed on day 14 using the Minor's iodine starch test to measure the anhydrotic area and dimensions.
Main Results:
- CBTX-A exhibited significantly greater anhidrosis area and dimensions (vertical and horizontal) compared to onabotulinumtoxinA for intradermal injections.
- Subcutaneous injections of CBTX-A resulted in a larger anhidrosis area than onabotulinumtoxinA.
- OnabotulinumtoxinA showed greater horizontal diffusion with subcutaneous compared to intradermal injections.
Conclusions:
- OnabotulinumtoxinA diffuses less extensively than CBTX-A.
- Intradermal injection technique appears to limit diffusion more than subcutaneous injection.
Related Concept Videos
Blinding
2.9K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
2.2K

